Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets

Report Code: BIO248A

Publish Date: Nov 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for biologics CDMOs is expected to increase from $15.1 billion in 2023 to $27.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2023-2028.

Report Includes

  • 40 data tables and 10 additional tables
  • An up-to-date overview and industry analysis of the global markets for biologics contract development and manufacturing organizations (CDMO)
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for biologics CDMO market in USD million values, and their corresponding market share analysis based on the product type, cell line type, and geographic region
  • In-depth information (facts and figures) concerning the market growth drivers, opportunities and challenges, prospects, technologies, regulatory scenarios, and the impact of macroeconomic variables on biologics CDMO marketplace
  • Discussion of ESG developments in global CDMO services market, with emphasis on importance of ESG, consumer attitudes, risks and opportunity assessment, and ESG followed practices
  • Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
  • Market outlook and opportunity assessment of the industry structure for biologics CDMO services, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
  • Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
  • Analysis of the company competitive landscape based on recent developments, key financials, and operational integration
  • Company profiles of major players within the industry, including Lonza Group, WuXi Biologics, Samsung Biologics, Boehringer Ingelheim, and Catalent Inc.

Report Scope

The scope of the report includes biologics CDMO services, industries, initiatives, patents, and companies. The markets for biologics CDMO are given for 2020, 2021, 2022, 2023 and 2028.

This report explains why biologics CDMO is important in pharmaceutical and biotechnology industry. It then discusses some of the significant research initiatives that are impacting biologics CDMO. The main market-driving forces are also discussed.

The report examines the markets by product type, cell line type and region. The report provides market data and forecasts for biologics CDMO by product type, including biologics and biosimilars. The specific regional markets covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW).

In the report BCC Research summarizes the main industry acquisitions and strategic alliances from January 2020 through December 2022.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $13.4 billion
Market size forecast $27.0 billion
Growth rate CAGR of 12.3% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Product Type, Cell Line Type
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
Key Market Drivers
  • Rising Prevalence of Cancer
  • Increasing Demand for Biologics
  • Rising Use of CDMOs
  • Increasing Elderly Population
Companies studied
ABBVIE CONTRACT MANUFACTURINGAGC BIOLOGICS
BOEHRINGER INGELHEIM INTERNATIONAL GMBHBINEX CO. LTD.
BIOVIAN OYBORA PHARMACEUTICAL CDMO
CATALENT INC.CYTOVANCE BIOLOGICS
EMERGENT BIOSOLUTIONS INC.FUJIFILM DIOSYNTH BIOTECHNOLOGIES
ICON PLCJRS PHARMA GMBH & CO. KG
KEMWELLLONZA
LOTTE BIOLOGICSPAREXEL INTERNATIONAL CORP.
RENTSCHLER BIOPHARMA SESAMSUNG BIOLOGICS
SANDOZ INTERNATIONAL GMBHTHERMO FISHER SCIENTIFIC INC.
TOYOBO CO. LTD.WUXI XDC
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The biologics CDMOs market is projected to grow from $13.4 billion in 2022 to $27.0 billion in 2028 at a compound annual growth rate (CAGR) of 12.3% during the forecast period.
The key factors driving the growth of the biologics CDMO market include increasing aging population, rising demand for biologicals, and heavy investments in healthcare infrastructure is boosting the growth of the biologics CDMO market.
The biologics CDMO market is segmented based on product type, cell line type, and by region.
The mammalian segment will dominate the biologics CDMO market by the end of 2028.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets131Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market Overview18Free
Chapter- 4: Market Dynamics3Free
Chapter- 5: Global Market for Biologics CDMOs by Product Type7Free
Chapter- 6: Global Market for Biologics CDMOs by Cell-Line Type8Free
Chapter- 7: Global Market for Biologics CDMOs by Region8Free
Chapter- 8: Sustainability in Biologics CDMOs: An ESG Perspective9Free
Chapter- 9: Emerging Technologies and Developments2Free
Chapter- 10: Regulatory Landscape7Free
Chapter- 11: M&A and Venture Funding Outlook4Free
Chapter- 12: Competitive Intelligence1Free
Chapter- 13: Company Profiles53Free
Chapter- 14: Appendix1Free

Related Reports

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Published - Sep 2021 | Publisher - BCC Publishing | Code - PHM043H

The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Sep 2020 | Publisher - BCC Publishing | Code - PHM238A

CDMO is an evolving industry with abundant growth opportunities for service providers. CDMO industry is trending towards consolidation; thus, CDMO companies are evolving as integrated pharmaceutical service providers or one-stop solution providers. This report provides details on the CDMO industry including the future trends and latest developments.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets
Sample Report